HEADER TRANSFERASE 14-SEP-09 3JU7 TITLE CRYSTAL STRUCTURE OF PUTATIVE PLP-DEPENDENT AMINOTRANSFERASE TITLE 2 (NP_978343.1) FROM BACILLUS CEREUS ATCC 10987 AT 2.19 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: PUTATIVE PLP-DEPENDENT AMINOTRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: DEGT/DNRJ/ERYC1/STRS FAMILY PROTEIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACILLUS CEREUS ATCC 10987; SOURCE 3 ORGANISM_TAXID: 222523; SOURCE 4 ATCC: 10987; SOURCE 5 GENE: BCE_2027, NP_978343.1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS NP_978343.1, PUTATIVE PLP-DEPENDENT AMINOTRANSFERASE, STRUCTURAL KEYWDS 2 GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN KEYWDS 3 STRUCTURE INITIATIVE, PSI-2, PYRIDOXAL PHOSPHATE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 4 24-JUL-19 3JU7 1 REMARK LINK REVDAT 3 01-NOV-17 3JU7 1 REMARK REVDAT 2 13-JUL-11 3JU7 1 VERSN REVDAT 1 10-NOV-09 3JU7 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF PUTATIVE PLP-DEPENDENT AMINOTRANSFERASE JRNL TITL 2 (NP_978343.1) FROM BACILLUS CEREUS ATCC 10987 AT 2.19 A JRNL TITL 3 RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.19 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0053 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.19 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.72 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 3 NUMBER OF REFLECTIONS : 50279 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.179 REMARK 3 R VALUE (WORKING SET) : 0.176 REMARK 3 FREE R VALUE : 0.220 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2571 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.19 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.25 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3427 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.09 REMARK 3 BIN R VALUE (WORKING SET) : 0.2380 REMARK 3 BIN FREE R VALUE SET COUNT : 177 REMARK 3 BIN FREE R VALUE : 0.2730 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5825 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 93 REMARK 3 SOLVENT ATOMS : 300 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 32.56 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.74 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.31000 REMARK 3 B22 (A**2) : -1.19000 REMARK 3 B33 (A**2) : -2.13000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.207 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.179 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.126 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 11.183 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.957 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.935 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 6064 ; 0.015 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 4133 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 8183 ; 1.544 ; 1.967 REMARK 3 BOND ANGLES OTHERS (DEGREES): 10080 ; 0.912 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 738 ; 5.578 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 258 ;34.043 ;24.419 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1035 ;13.931 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 26 ;17.562 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 882 ; 0.087 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6632 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 1216 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3677 ; 1.587 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1494 ; 0.549 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5909 ; 2.685 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2387 ; 5.125 ; 8.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2272 ; 7.231 ;11.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 2 A 369 5 REMARK 3 1 B 2 B 369 5 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 1 A (A): 2168 ; 0.110 ; 0.500 REMARK 3 LOOSE POSITIONAL 1 A (A): 2739 ; 0.330 ; 5.000 REMARK 3 MEDIUM THERMAL 1 A (A**2): 2168 ; 0.790 ; 2.000 REMARK 3 LOOSE THERMAL 1 A (A**2): 2739 ; 1.030 ;10.000 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 2 A 369 REMARK 3 ORIGIN FOR THE GROUP (A): 9.9060 57.7432 77.7198 REMARK 3 T TENSOR REMARK 3 T11: 0.0601 T22: 0.0295 REMARK 3 T33: 0.0066 T12: 0.0144 REMARK 3 T13: -0.0017 T23: 0.0056 REMARK 3 L TENSOR REMARK 3 L11: 0.9270 L22: 0.8895 REMARK 3 L33: 0.8720 L12: -0.3932 REMARK 3 L13: -0.3161 L23: 0.1717 REMARK 3 S TENSOR REMARK 3 S11: 0.1064 S12: 0.1493 S13: 0.0533 REMARK 3 S21: -0.2275 S22: -0.0543 S23: 0.0086 REMARK 3 S31: -0.0276 S32: 0.0006 S33: -0.0521 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 2 B 369 REMARK 3 ORIGIN FOR THE GROUP (A): 12.8671 60.0429 110.5372 REMARK 3 T TENSOR REMARK 3 T11: 0.0523 T22: 0.0494 REMARK 3 T33: 0.0154 T12: 0.0072 REMARK 3 T13: -0.0071 T23: -0.0248 REMARK 3 L TENSOR REMARK 3 L11: 0.5311 L22: 0.9860 REMARK 3 L33: 0.9897 L12: -0.1435 REMARK 3 L13: 0.0531 L23: -0.3686 REMARK 3 S TENSOR REMARK 3 S11: -0.0273 S12: -0.1440 S13: 0.0664 REMARK 3 S21: 0.2014 S22: 0.0799 S23: -0.0505 REMARK 3 S31: -0.1047 S32: 0.0312 S33: -0.0526 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1.HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. 2.ATOM RECORDS CONTAIN RESIDUAL B FACTORS REMARK 3 ONLY. 3.A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE REMARK 3 INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY OF THE SE REMARK 3 ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 FOR THE REDUCED REMARK 3 SCATTERING POWER DUE TO PARTIAL S-MET INCORPORATION. 4.RESIDUE REMARK 3 LYS190 IN BOTH CHAINS HAS BEEN MODIFIED BY COVALENT MODIFICATION REMARK 3 WITH PLP VIA A SCHIFF BASE FORMATION BETWEEN THE LYSINE AND THE REMARK 3 PLP AND IS MODELED AS LLP. 5.CALCIUM (CA), ACETATE (ACT) AND REMARK 3 PEG300 FRAGMENTS (PEG, PGE) FROM THE CRYSTALLIZATION SOLUTION REMARK 3 HAVE BEEN MODELED IN THE SOLVENT STRUCTURE. REMARK 4 REMARK 4 3JU7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-SEP-09. REMARK 100 THE DEPOSITION ID IS D_1000055164. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-MAY-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL12-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97927 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL MONOCHROMATOR REMARK 200 OPTICS : FLAT MIRROR, VERTICAL AND REMARK 200 HORIZONTAL FOCUSSING MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 50328 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.190 REMARK 200 RESOLUTION RANGE LOW (A) : 44.721 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.13600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.8300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.19 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.27 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.70400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: SHELX, SHELXD, AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.76 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.78 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2000M CALCIUM ACETATE, 40.0000% REMARK 280 POLYETHYLENE GLYCOL 300, 0.1M SODIUM CACODYLATE PH 6.5, ADDITIVE: REMARK 280 0.001 M PLP, NANODROP, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 41.19400 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 65.84950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.29300 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 65.84950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 41.19400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.29300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: CRYSTAL PACKING ANALYSIS SUPPORTS THE ASSIGNMENT OF A DIMER REMARK 300 AS THE SIGNIFICANT OLIGOMERIC FORM IN SOLUTION. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9010 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25530 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 MSE A 1 REMARK 465 LYS A 370 REMARK 465 VAL A 371 REMARK 465 VAL A 372 REMARK 465 SER A 373 REMARK 465 ALA A 374 REMARK 465 ASP A 375 REMARK 465 GLU A 376 REMARK 465 GLY B 0 REMARK 465 MSE B 1 REMARK 465 LYS B 370 REMARK 465 VAL B 371 REMARK 465 VAL B 372 REMARK 465 SER B 373 REMARK 465 ALA B 374 REMARK 465 ASP B 375 REMARK 465 GLU B 376 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 2 CG CD OE1 OE2 REMARK 470 ASN A 3 CG OD1 ND2 REMARK 470 GLN A 42 CG CD OE1 NE2 REMARK 470 LYS A 75 CD CE NZ REMARK 470 LYS A 76 CD CE NZ REMARK 470 LYS A 126 CE NZ REMARK 470 GLU A 145 CG CD OE1 OE2 REMARK 470 LYS A 153 CE NZ REMARK 470 GLU A 206 CD OE1 OE2 REMARK 470 LYS A 254 CG CD CE NZ REMARK 470 LYS A 274 CG CD CE NZ REMARK 470 LYS A 275 CG CD CE NZ REMARK 470 LYS A 281 CG CD CE NZ REMARK 470 ARG A 299 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 310 CG CD OE1 NE2 REMARK 470 LYS A 311 CG CD CE NZ REMARK 470 LYS A 344 CD CE NZ REMARK 470 GLN A 369 CG CD OE1 NE2 REMARK 470 GLU B 2 CG CD OE1 OE2 REMARK 470 GLN B 42 CD OE1 NE2 REMARK 470 LYS B 75 CG CD CE NZ REMARK 470 LYS B 76 CD CE NZ REMARK 470 LYS B 126 CE NZ REMARK 470 GLU B 145 CG CD OE1 OE2 REMARK 470 LYS B 153 CD CE NZ REMARK 470 GLU B 206 CG CD OE1 OE2 REMARK 470 GLN B 268 CG CD OE1 NE2 REMARK 470 LYS B 274 CG CD CE NZ REMARK 470 LYS B 281 CD CE NZ REMARK 470 GLU B 297 CG CD OE1 OE2 REMARK 470 ARG B 299 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 309 CD CE NZ REMARK 470 GLN B 310 CG CD OE1 NE2 REMARK 470 LYS B 311 CG CD CE NZ REMARK 470 LYS B 344 CE NZ REMARK 470 GLN B 362 CD OE1 NE2 REMARK 470 GLN B 369 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B 213 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 31 -166.93 -165.42 REMARK 500 LYS A 126 -129.06 53.37 REMARK 500 PHE A 230 -157.09 -167.72 REMARK 500 THR B 31 -165.10 -163.06 REMARK 500 ASN B 51 29.87 48.96 REMARK 500 LYS B 126 -119.12 49.25 REMARK 500 ASP B 177 16.97 52.86 REMARK 500 PHE B 230 -158.63 -162.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 377 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 378 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 379 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 380 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 381 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 382 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG A 383 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG A 384 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG A 385 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PGE A 386 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA B 377 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B 378 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B 379 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG B 380 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG B 381 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG B 382 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG B 383 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PGE B 384 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 390490 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THIS CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING REMARK 999 ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. DBREF 3JU7 A 1 376 UNP Q739W0 Q739W0_BACC1 1 376 DBREF 3JU7 B 1 376 UNP Q739W0 Q739W0_BACC1 1 376 SEQADV 3JU7 GLY A 0 UNP Q739W0 LEADER SEQUENCE SEQADV 3JU7 GLY B 0 UNP Q739W0 LEADER SEQUENCE SEQRES 1 A 377 GLY MSE GLU ASN ILE PRO PHE LEU ARG ALA SER THR VAL SEQRES 2 A 377 PRO VAL ILE GLU TYR LEU ASP GLU LEU LYS GLU ILE ASP SEQRES 3 A 377 ALA SER HIS ILE TYR THR ASN TYR GLY PRO ILE ASN GLN SEQRES 4 A 377 ARG PHE GLU GLN THR ILE MSE SER GLY PHE PHE GLN ASN SEQRES 5 A 377 ARG GLY ALA VAL THR THR VAL ALA ASN ALA THR LEU GLY SEQRES 6 A 377 LEU MSE ALA ALA ILE GLN LEU LYS LYS ARG LYS LYS GLY SEQRES 7 A 377 LYS TYR ALA LEU MSE PRO SER PHE THR PHE PRO ALA THR SEQRES 8 A 377 PRO LEU ALA ALA ILE TRP CYS GLY LEU GLU PRO TYR PHE SEQRES 9 A 377 ILE ASP ILE SER ILE ASP ASP TRP TYR MSE ASP LYS THR SEQRES 10 A 377 VAL LEU TRP ASP LYS ILE GLU GLU LEU LYS GLU GLU VAL SEQRES 11 A 377 ALA ILE VAL VAL PRO TYR ALA THR PHE GLY SER TRP MSE SEQRES 12 A 377 ASN LEU GLU GLU TYR GLU GLU LEU GLU LYS LYS GLY VAL SEQRES 13 A 377 PRO VAL VAL VAL ASP ALA ALA PRO GLY PHE GLY LEU MSE SEQRES 14 A 377 ASN GLY GLY MSE HIS TYR GLY GLN ASP PHE SER GLY MSE SEQRES 15 A 377 ILE ILE TYR SER PHE HIS ALA THR LLP PRO PHE GLY ILE SEQRES 16 A 377 GLY GLU GLY GLY LEU ILE TYR SER LYS ASN GLU GLU ASP SEQRES 17 A 377 ILE GLN ARG ILE LYS ARG MSE GLY ASN PHE GLY PHE ASP SEQRES 18 A 377 THR ASN ARG GLU CYS THR MSE MSE GLY PHE ASN CYS LYS SEQRES 19 A 377 MSE SER GLU TYR ALA ALA ALA ILE GLY ILE ALA THR MSE SEQRES 20 A 377 LYS LYS TRP ASP ASP LYS LEU LYS GLU ARG THR ARG ILE SEQRES 21 A 377 SER GLU TRP TYR LYS GLN LEU LEU GLN SER ASN GLY LEU SEQRES 22 A 377 MSE LYS LYS GLY TRP GLN LEU GLN LYS THR GLU ALA VAL SEQRES 23 A 377 ILE GLN GLN PHE MSE PRO ILE LEU CYS PRO GLU GLU VAL SEQRES 24 A 377 ARG ASN LYS GLN VAL ILE GLU ASP LEU LYS LYS GLN LYS SEQRES 25 A 377 ILE GLU ALA ARG LEU TYR PHE SER PRO SER CYS HIS GLN SEQRES 26 A 377 GLN VAL LEU PHE ARG ASN TYR LYS SER THR ASP LEU THR SEQRES 27 A 377 ARG THR ASN LYS ILE ALA LYS ARG ILE VAL SER LEU PRO SEQRES 28 A 377 LEU TRP GLU GLY MSE THR LYS GLU ILE VAL GLU GLN ILE SEQRES 29 A 377 VAL ILE CYS LEU GLY GLN LYS VAL VAL SER ALA ASP GLU SEQRES 1 B 377 GLY MSE GLU ASN ILE PRO PHE LEU ARG ALA SER THR VAL SEQRES 2 B 377 PRO VAL ILE GLU TYR LEU ASP GLU LEU LYS GLU ILE ASP SEQRES 3 B 377 ALA SER HIS ILE TYR THR ASN TYR GLY PRO ILE ASN GLN SEQRES 4 B 377 ARG PHE GLU GLN THR ILE MSE SER GLY PHE PHE GLN ASN SEQRES 5 B 377 ARG GLY ALA VAL THR THR VAL ALA ASN ALA THR LEU GLY SEQRES 6 B 377 LEU MSE ALA ALA ILE GLN LEU LYS LYS ARG LYS LYS GLY SEQRES 7 B 377 LYS TYR ALA LEU MSE PRO SER PHE THR PHE PRO ALA THR SEQRES 8 B 377 PRO LEU ALA ALA ILE TRP CYS GLY LEU GLU PRO TYR PHE SEQRES 9 B 377 ILE ASP ILE SER ILE ASP ASP TRP TYR MSE ASP LYS THR SEQRES 10 B 377 VAL LEU TRP ASP LYS ILE GLU GLU LEU LYS GLU GLU VAL SEQRES 11 B 377 ALA ILE VAL VAL PRO TYR ALA THR PHE GLY SER TRP MSE SEQRES 12 B 377 ASN LEU GLU GLU TYR GLU GLU LEU GLU LYS LYS GLY VAL SEQRES 13 B 377 PRO VAL VAL VAL ASP ALA ALA PRO GLY PHE GLY LEU MSE SEQRES 14 B 377 ASN GLY GLY MSE HIS TYR GLY GLN ASP PHE SER GLY MSE SEQRES 15 B 377 ILE ILE TYR SER PHE HIS ALA THR LLP PRO PHE GLY ILE SEQRES 16 B 377 GLY GLU GLY GLY LEU ILE TYR SER LYS ASN GLU GLU ASP SEQRES 17 B 377 ILE GLN ARG ILE LYS ARG MSE GLY ASN PHE GLY PHE ASP SEQRES 18 B 377 THR ASN ARG GLU CYS THR MSE MSE GLY PHE ASN CYS LYS SEQRES 19 B 377 MSE SER GLU TYR ALA ALA ALA ILE GLY ILE ALA THR MSE SEQRES 20 B 377 LYS LYS TRP ASP ASP LYS LEU LYS GLU ARG THR ARG ILE SEQRES 21 B 377 SER GLU TRP TYR LYS GLN LEU LEU GLN SER ASN GLY LEU SEQRES 22 B 377 MSE LYS LYS GLY TRP GLN LEU GLN LYS THR GLU ALA VAL SEQRES 23 B 377 ILE GLN GLN PHE MSE PRO ILE LEU CYS PRO GLU GLU VAL SEQRES 24 B 377 ARG ASN LYS GLN VAL ILE GLU ASP LEU LYS LYS GLN LYS SEQRES 25 B 377 ILE GLU ALA ARG LEU TYR PHE SER PRO SER CYS HIS GLN SEQRES 26 B 377 GLN VAL LEU PHE ARG ASN TYR LYS SER THR ASP LEU THR SEQRES 27 B 377 ARG THR ASN LYS ILE ALA LYS ARG ILE VAL SER LEU PRO SEQRES 28 B 377 LEU TRP GLU GLY MSE THR LYS GLU ILE VAL GLU GLN ILE SEQRES 29 B 377 VAL ILE CYS LEU GLY GLN LYS VAL VAL SER ALA ASP GLU MODRES 3JU7 MSE A 45 MET SELENOMETHIONINE MODRES 3JU7 MSE A 66 MET SELENOMETHIONINE MODRES 3JU7 MSE A 82 MET SELENOMETHIONINE MODRES 3JU7 MSE A 113 MET SELENOMETHIONINE MODRES 3JU7 MSE A 142 MET SELENOMETHIONINE MODRES 3JU7 MSE A 168 MET SELENOMETHIONINE MODRES 3JU7 MSE A 172 MET SELENOMETHIONINE MODRES 3JU7 MSE A 181 MET SELENOMETHIONINE MODRES 3JU7 LLP A 190 LYS MODRES 3JU7 MSE A 214 MET SELENOMETHIONINE MODRES 3JU7 MSE A 227 MET SELENOMETHIONINE MODRES 3JU7 MSE A 228 MET SELENOMETHIONINE MODRES 3JU7 MSE A 234 MET SELENOMETHIONINE MODRES 3JU7 MSE A 246 MET SELENOMETHIONINE MODRES 3JU7 MSE A 273 MET SELENOMETHIONINE MODRES 3JU7 MSE A 290 MET SELENOMETHIONINE MODRES 3JU7 MSE A 355 MET SELENOMETHIONINE MODRES 3JU7 MSE B 45 MET SELENOMETHIONINE MODRES 3JU7 MSE B 66 MET SELENOMETHIONINE MODRES 3JU7 MSE B 82 MET SELENOMETHIONINE MODRES 3JU7 MSE B 113 MET SELENOMETHIONINE MODRES 3JU7 MSE B 142 MET SELENOMETHIONINE MODRES 3JU7 MSE B 168 MET SELENOMETHIONINE MODRES 3JU7 MSE B 172 MET SELENOMETHIONINE MODRES 3JU7 MSE B 181 MET SELENOMETHIONINE MODRES 3JU7 LLP B 190 LYS MODRES 3JU7 MSE B 214 MET SELENOMETHIONINE MODRES 3JU7 MSE B 227 MET SELENOMETHIONINE MODRES 3JU7 MSE B 228 MET SELENOMETHIONINE MODRES 3JU7 MSE B 234 MET SELENOMETHIONINE MODRES 3JU7 MSE B 246 MET SELENOMETHIONINE MODRES 3JU7 MSE B 273 MET SELENOMETHIONINE MODRES 3JU7 MSE B 290 MET SELENOMETHIONINE MODRES 3JU7 MSE B 355 MET SELENOMETHIONINE HET MSE A 45 8 HET MSE A 66 8 HET MSE A 82 8 HET MSE A 113 8 HET MSE A 142 8 HET MSE A 168 8 HET MSE A 172 8 HET MSE A 181 8 HET LLP A 190 24 HET MSE A 214 8 HET MSE A 227 8 HET MSE A 228 8 HET MSE A 234 8 HET MSE A 246 8 HET MSE A 273 8 HET MSE A 290 8 HET MSE A 355 8 HET MSE B 45 8 HET MSE B 66 8 HET MSE B 82 8 HET MSE B 113 8 HET MSE B 142 8 HET MSE B 168 8 HET MSE B 172 8 HET MSE B 181 8 HET LLP B 190 24 HET MSE B 214 8 HET MSE B 227 8 HET MSE B 228 8 HET MSE B 234 8 HET MSE B 246 8 HET MSE B 273 8 HET MSE B 290 8 HET MSE B 355 8 HET CA A 377 1 HET CA A 378 1 HET CA A 379 1 HET ACT A 380 4 HET ACT A 381 4 HET ACT A 382 4 HET PEG A 383 7 HET PEG A 384 7 HET PEG A 385 7 HET PGE A 386 10 HET CA B 377 1 HET ACT B 378 4 HET ACT B 379 4 HET PEG B 380 7 HET PEG B 381 7 HET PEG B 382 7 HET PEG B 383 7 HET PGE B 384 10 HETNAM MSE SELENOMETHIONINE HETNAM LLP (2S)-2-AMINO-6-[[3-HYDROXY-2-METHYL-5- HETNAM 2 LLP (PHOSPHONOOXYMETHYL)PYRIDIN-4- HETNAM 3 LLP YL]METHYLIDENEAMINO]HEXANOIC ACID HETNAM CA CALCIUM ION HETNAM ACT ACETATE ION HETNAM PEG DI(HYDROXYETHYL)ETHER HETNAM PGE TRIETHYLENE GLYCOL HETSYN LLP N'-PYRIDOXYL-LYSINE-5'-MONOPHOSPHATE FORMUL 1 MSE 32(C5 H11 N O2 SE) FORMUL 1 LLP 2(C14 H22 N3 O7 P) FORMUL 3 CA 4(CA 2+) FORMUL 6 ACT 5(C2 H3 O2 1-) FORMUL 9 PEG 7(C4 H10 O3) FORMUL 12 PGE 2(C6 H14 O4) FORMUL 21 HOH *300(H2 O) HELIX 1 1 PRO A 13 GLU A 16 5 4 HELIX 2 2 TYR A 17 HIS A 28 1 12 HELIX 3 3 GLY A 34 PHE A 48 1 15 HELIX 4 4 ASN A 60 LYS A 73 1 14 HELIX 5 5 PRO A 88 CYS A 97 1 10 HELIX 6 6 ASP A 114 LYS A 126 1 13 HELIX 7 7 ALA A 136 SER A 140 5 5 HELIX 8 8 LEU A 144 LYS A 153 1 10 HELIX 9 9 ASN A 204 GLY A 215 1 12 HELIX 10 10 SER A 235 LYS A 248 1 14 HELIX 11 11 LYS A 248 ASN A 270 1 23 HELIX 12 12 ARG A 299 LYS A 309 1 11 HELIX 13 13 SER A 321 ARG A 329 5 9 HELIX 14 14 LEU A 336 ARG A 345 1 10 HELIX 15 15 THR A 356 GLY A 368 1 13 HELIX 16 16 PRO B 13 GLU B 16 5 4 HELIX 17 17 TYR B 17 HIS B 28 1 12 HELIX 18 18 GLY B 34 PHE B 48 1 15 HELIX 19 19 ASN B 60 LYS B 73 1 14 HELIX 20 20 PRO B 88 CYS B 97 1 10 HELIX 21 21 ASP B 114 LYS B 126 1 13 HELIX 22 22 LEU B 144 GLY B 154 1 11 HELIX 23 23 ASN B 204 GLY B 215 1 12 HELIX 24 24 SER B 235 ASN B 270 1 36 HELIX 25 25 ARG B 299 GLN B 310 1 12 HELIX 26 26 SER B 321 ARG B 329 5 9 HELIX 27 27 LEU B 336 ARG B 345 1 10 HELIX 28 28 THR B 356 GLN B 369 1 14 SHEET 1 A 4 ALA A 54 VAL A 58 0 SHEET 2 A 4 GLY A 198 SER A 202 -1 O SER A 202 N ALA A 54 SHEET 3 A 4 MSE A 181 SER A 185 -1 N TYR A 184 O LEU A 199 SHEET 4 A 4 VAL A 158 ASP A 160 1 N VAL A 159 O MSE A 181 SHEET 1 B 3 GLU A 100 ILE A 104 0 SHEET 2 B 3 TYR A 79 PRO A 83 1 N ALA A 80 O GLU A 100 SHEET 3 B 3 VAL A 129 VAL A 132 1 O ALA A 130 N TYR A 79 SHEET 1 C 2 MSE A 168 ASN A 169 0 SHEET 2 C 2 MSE A 172 HIS A 173 -1 O MSE A 172 N ASN A 169 SHEET 1 D 2 MSE A 290 LEU A 293 0 SHEET 2 D 2 ILE A 346 LEU A 349 -1 O LEU A 349 N MSE A 290 SHEET 1 E 4 ALA B 54 VAL B 58 0 SHEET 2 E 4 GLY B 198 SER B 202 -1 O ILE B 200 N THR B 56 SHEET 3 E 4 MSE B 181 SER B 185 -1 N TYR B 184 O LEU B 199 SHEET 4 E 4 VAL B 158 ASP B 160 1 N VAL B 159 O MSE B 181 SHEET 1 F 3 GLU B 100 ILE B 104 0 SHEET 2 F 3 TYR B 79 PRO B 83 1 N ALA B 80 O GLU B 100 SHEET 3 F 3 VAL B 129 VAL B 132 1 O ALA B 130 N TYR B 79 SHEET 1 G 2 MSE B 168 ASN B 169 0 SHEET 2 G 2 MSE B 172 HIS B 173 -1 O MSE B 172 N ASN B 169 SHEET 1 H 2 MSE B 290 LEU B 293 0 SHEET 2 H 2 ILE B 346 LEU B 349 -1 O LEU B 349 N MSE B 290 LINK C ILE A 44 N MSE A 45 1555 1555 1.32 LINK C MSE A 45 N SER A 46 1555 1555 1.32 LINK C LEU A 65 N MSE A 66 1555 1555 1.33 LINK C MSE A 66 N ALA A 67 1555 1555 1.33 LINK C LEU A 81 N MSE A 82 1555 1555 1.32 LINK C MSE A 82 N PRO A 83 1555 1555 1.32 LINK C TYR A 112 N MSE A 113 1555 1555 1.32 LINK C MSE A 113 N ASP A 114 1555 1555 1.33 LINK C TRP A 141 N MSE A 142 1555 1555 1.33 LINK C MSE A 142 N ASN A 143 1555 1555 1.33 LINK C LEU A 167 N MSE A 168 1555 1555 1.33 LINK C MSE A 168 N ASN A 169 1555 1555 1.32 LINK C GLY A 171 N MSE A 172 1555 1555 1.32 LINK C MSE A 172 N HIS A 173 1555 1555 1.34 LINK C GLY A 180 N MSE A 181 1555 1555 1.33 LINK C MSE A 181 N ILE A 182 1555 1555 1.33 LINK C THR A 189 N LLP A 190 1555 1555 1.33 LINK C LLP A 190 N PRO A 191 1555 1555 1.34 LINK C ARG A 213 N MSE A 214 1555 1555 1.34 LINK C MSE A 214 N GLY A 215 1555 1555 1.33 LINK C THR A 226 N MSE A 227 1555 1555 1.33 LINK C MSE A 227 N MSE A 228 1555 1555 1.31 LINK C MSE A 228 N GLY A 229 1555 1555 1.32 LINK C LYS A 233 N MSE A 234 1555 1555 1.32 LINK C MSE A 234 N SER A 235 1555 1555 1.33 LINK C THR A 245 N MSE A 246 1555 1555 1.34 LINK C MSE A 246 N LYS A 247 1555 1555 1.33 LINK C LEU A 272 N MSE A 273 1555 1555 1.33 LINK C MSE A 273 N LYS A 274 1555 1555 1.34 LINK C PHE A 289 N MSE A 290 1555 1555 1.34 LINK C MSE A 290 N PRO A 291 1555 1555 1.33 LINK C GLY A 354 N MSE A 355 1555 1555 1.33 LINK C MSE A 355 N THR A 356 1555 1555 1.33 LINK C ILE B 44 N MSE B 45 1555 1555 1.33 LINK C MSE B 45 N SER B 46 1555 1555 1.33 LINK C LEU B 65 N MSE B 66 1555 1555 1.34 LINK C MSE B 66 N ALA B 67 1555 1555 1.34 LINK C LEU B 81 N MSE B 82 1555 1555 1.33 LINK C MSE B 82 N PRO B 83 1555 1555 1.34 LINK C TYR B 112 N MSE B 113 1555 1555 1.31 LINK C MSE B 113 N ASP B 114 1555 1555 1.33 LINK C TRP B 141 N MSE B 142 1555 1555 1.32 LINK C MSE B 142 N ASN B 143 1555 1555 1.33 LINK C LEU B 167 N MSE B 168 1555 1555 1.33 LINK C MSE B 168 N ASN B 169 1555 1555 1.31 LINK C GLY B 171 N MSE B 172 1555 1555 1.32 LINK C MSE B 172 N HIS B 173 1555 1555 1.32 LINK C GLY B 180 N MSE B 181 1555 1555 1.33 LINK C MSE B 181 N ILE B 182 1555 1555 1.34 LINK C THR B 189 N LLP B 190 1555 1555 1.32 LINK C LLP B 190 N PRO B 191 1555 1555 1.35 LINK C ARG B 213 N MSE B 214 1555 1555 1.32 LINK C MSE B 214 N GLY B 215 1555 1555 1.33 LINK C THR B 226 N MSE B 227 1555 1555 1.33 LINK C MSE B 227 N MSE B 228 1555 1555 1.33 LINK C MSE B 228 N GLY B 229 1555 1555 1.32 LINK C LYS B 233 N MSE B 234 1555 1555 1.32 LINK C MSE B 234 N SER B 235 1555 1555 1.31 LINK C THR B 245 N MSE B 246 1555 1555 1.33 LINK C MSE B 246 N LYS B 247 1555 1555 1.33 LINK C LEU B 272 N MSE B 273 1555 1555 1.34 LINK C MSE B 273 N LYS B 274 1555 1555 1.33 LINK C PHE B 289 N MSE B 290 1555 1555 1.32 LINK C MSE B 290 N PRO B 291 1555 1555 1.34 LINK C GLY B 354 N MSE B 355 1555 1555 1.33 LINK C MSE B 355 N THR B 356 1555 1555 1.33 CISPEP 1 TYR A 317 PHE A 318 0 9.28 CISPEP 2 SER A 319 PRO A 320 0 2.30 CISPEP 3 TYR B 317 PHE B 318 0 4.99 CISPEP 4 SER B 319 PRO B 320 0 3.65 SITE 1 AC1 4 ASP A 19 CA A 379 HOH A 530 HOH A 531 SITE 1 AC2 4 HOH A 533 ARG B 329 HOH B 521 HOH B 535 SITE 1 AC3 6 ASP A 19 CA A 377 HOH A 531 HOH A 532 SITE 2 AC3 6 HOH A 534 ASN B 330 SITE 1 AC4 7 ASN A 32 PHE A 217 ASN A 231 LYS A 233 SITE 2 AC4 7 HOH A 421 HIS B 187 LLP B 190 SITE 1 AC5 6 ARG A 223 HOH A 396 HOH A 398 ARG B 315 SITE 2 AC5 6 LEU B 316 TYR B 317 SITE 1 AC6 1 LYS A 152 SITE 1 AC7 3 THR A 221 ASN A 222 ARG A 223 SITE 1 AC8 5 THR A 189 LLP A 190 GLN A 288 HOH A 443 SITE 2 AC8 5 ACT B 378 SITE 1 AC9 4 LYS A 264 THR A 282 GLU A 283 GLN A 287 SITE 1 BC1 8 TRP A 141 LEU A 144 GLU A 145 MSE A 172 SITE 2 BC1 8 GLY A 175 GLN A 176 ASP A 177 HOH A 527 SITE 1 BC2 4 HOH A 528 ASP B 19 HOH B 520 HOH B 534 SITE 1 BC3 8 HIS A 187 LLP A 190 PEG A 384 ASN B 32 SITE 2 BC3 8 PHE B 217 ASN B 231 LYS B 233 HOH B 475 SITE 1 BC4 6 ARG A 315 LEU A 316 TYR A 317 ARG B 223 SITE 2 BC4 6 HOH B 405 HOH B 461 SITE 1 BC5 2 THR B 221 ASN B 222 SITE 1 BC6 6 THR B 189 LLP B 190 GLN B 288 TYR B 317 SITE 2 BC6 6 HOH B 517 HOH B 531 SITE 1 BC7 3 PHE B 48 MSE B 168 ASP B 250 SITE 1 BC8 5 LYS B 264 GLN B 280 THR B 282 GLU B 283 SITE 2 BC8 5 GLN B 287 SITE 1 BC9 7 TRP B 141 ASN B 143 LEU B 144 GLU B 145 SITE 2 BC9 7 TYR B 174 GLY B 175 ASP B 177 CRYST1 82.388 90.586 131.699 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012138 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011039 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007593 0.00000 MASTER 495 0 52 28 22 0 28 6 0 0 0 58 END